Claudio Montuori

Department Of Head And Neck Surgery
Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.

Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.

Journal: The Lancet. Respiratory medicine

Published: February 11, 2026

Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinics.

Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinics.

Journal: Rhinology

Published: January 12, 2026

When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications.

When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications.

Journal: Expert review of respiratory medicine

Published: December 13, 2025

Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics.

Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics.

Journal: Current allergy and asthma reports

Published: November 14, 2025

Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm.

Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm.

Journal: Rhinology

Published: October 27, 2025

Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.

Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.

Journal: Current allergy and asthma reports

Published: July 17, 2025

One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.

One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.

Journal: Rhinology

Published: July 09, 2025

Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.

Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.

Journal: Allergy

Published: May 07, 2025

Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population.

Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population.

Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

Published: April 01, 2025

Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP: A Two-Year Real-World Study.

Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP: A Two-Year Real-World Study.

Journal: The Laryngoscope

Published: December 26, 2024

Thoracic aorta aneurysm tracheal compression and anatomical variant of the right subclavian artery: A case report.

Thoracic aorta aneurysm tracheal compression and anatomical variant of the right subclavian artery: A case report.

Journal: Radiology case reports

Published: November 07, 2024

Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.

Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.

Journal: Journal of personalized medicine

Published: June 03, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026